1.93
Schlusskurs vom Vortag:
$2.00
Offen:
$1.98
24-Stunden-Volumen:
4.78M
Relative Volume:
0.28
Marktkapitalisierung:
$244.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-112.46M
KGV:
-1.1768
EPS:
-1.64
Netto-Cashflow:
$-99.89M
1W Leistung:
-3.98%
1M Leistung:
-8.53%
6M Leistung:
+119.29%
1J Leistung:
+128.40%
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Vergleichen Sie VOR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
VOR
Vor Biopharma Inc
|
1.93 | 258.43M | 0 | -112.46M | -99.89M | -1.64 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2022-07-26 | Eingeleitet | Wedbush | Outperform |
2022-04-27 | Eingeleitet | Goldman | Neutral |
2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
2021-03-03 | Eingeleitet | Barclays | Overweight |
2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
2021-03-02 | Eingeleitet | Goldman | Sell |
2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Using flow based indicators on Vor Biopharma Inc.Dividend Hike & Safe Capital Growth Stock Tips - Newser
Trend analysis for Vor Biopharma Inc. this weekEarnings Miss & Long-Term Growth Stock Strategies - Newser
What’s next for Vor Biopharma Inc. stock priceJuly 2025 Highlights & Risk Controlled Stock Alerts - Newser
Does Vor Biopharma Inc. fit your quant trading modelPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser
How to integrate Vor Biopharma Inc. into portfolio analysis toolsJuly 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Multi factor analysis applied to Vor Biopharma Inc.July 2025 Earnings & Weekly Top Gainers Trade List - Newser
Does Vor Biopharma Inc. show high probability of reboundJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Using data filters to optimize entry into Vor Biopharma Inc.2025 Winners & Losers & Free Community Supported Trade Ideas - Newser
Real time social sentiment graph for Vor Biopharma Inc.Trade Volume Report & Risk Controlled Daily Plans - Newser
Custom strategy builders for tracking Vor Biopharma Inc.Quarterly Earnings Summary & Real-Time Volume Analysis - Newser
Quantitative breakdown of Vor Biopharma Inc. recent move2025 Major Catalysts & Accurate Technical Buy Alerts - Newser
Sector ETF performance correlation with Vor Biopharma Inc.Quarterly Profit Review & Weekly Breakout Stock Alerts - Newser
Risk vs reward if holding onto Vor Biopharma Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
What is Vor Biopharma Inc.’s book value per share2025 Big Picture & Technical Pattern Based Buy Signals - خودرو بانک
How cyclical is Vor Biopharma Inc.’s revenue streamJuly 2025 Gainers & Reliable Price Action Trade Plans - khodrobank.com
Vor Biopharma Focuses on Telitacicept Development Strategy - MSN
Price momentum metrics for Vor Biopharma Inc. explainedJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Can Vor Biopharma Inc. recover in the next quarterIPO Watch & Expert Curated Trade Ideas - Newser
Can Vor Biopharma Inc. lead its sector in growthJuly 2025 Momentum & Long-Term Growth Portfolio Plans - khodrobank.com
Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel - Yahoo Finance
Best data tools to analyze Vor Biopharma Inc. stockWeekly Investment Summary & Fast Exit and Entry Trade Guides - Newser
Applying chart zones and confluence areas to Vor Biopharma Inc.Weekly Investment Recap & Community Supported Trade Ideas - Newser
Chart based analysis of Vor Biopharma Inc. trendsEarnings Overview Report & Low Drawdown Trading Techniques - Newser
Support Zone Holds Steady for Vor Biopharma Inc. After Dip getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Vor Biopharma Inc. a strong growth stock2025 Trade Ideas & Smart Money Movement Tracker - khodrobank.com
Building trade automation scripts for Vor Biopharma Inc.2025 Top Gainers & High Conviction Buy Zone Alerts - Newser
What data driven models say about Vor Biopharma Inc.’s futureJuly 2025 Setups & Verified Momentum Stock Watchlist - Newser
Chart overlay techniques for tracking Vor Biopharma Inc.Trade Risk Summary & Community Trade Idea Sharing - Newser
Strategies to average down on Vor Biopharma Inc.Weekly Market Report & Low Drawdown Momentum Ideas - Newser
Using data filters to optimize entry into Vor Biopharma IncWeekly Investment Summary & Free Long-Term Investment Growth Plans - Newser
Can Vor Biopharma Inc. grow without external fundingWeekly Market Outlook & Weekly Setup with ROI Potential - sundaytimes.kr
Is Vor Biopharma Inc. likely to announce a buybackWeekly Trend Summary & Reliable Volume Spike Alerts - kpenews.com
Has Vor Biopharma Inc. formed a bullish divergence2025 Volume Leaders & Expert Curated Trade Ideas - Newser
Why Vor Biopharma Inc. stock attracts strong analyst attentionWeekly Market Outlook & Low Volatility Stock Suggestions - Newser
What MACD signals say about Vor Biopharma Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
Traders Watching For Reversal Pattern in Vor Biopharma Inc.2025 Stock Rankings & AI Enhanced Trading Signals - beatles.ru
Published on: 2025-08-31 01:54:38 - beatles.ru
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vor Biopharma Inc-Aktie (VOR) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Reprogrammed Interchange LLC | 10% Owner |
Aug 28 '25 |
Sale |
2.01 |
806,351 |
1,621,975 |
36,884,567 |
Reprogrammed Interchange LLC | 10% Owner |
Aug 27 '25 |
Sale |
2.01 |
611,647 |
1,226,536 |
37,690,918 |
Reprogrammed Interchange LLC | 10% Owner |
Aug 25 '25 |
Sale |
2.12 |
387,346 |
819,740 |
38,586,755 |
Reprogrammed Interchange LLC | 10% Owner |
Aug 26 '25 |
Sale |
2.08 |
284,190 |
591,343 |
38,302,565 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):